Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
ABBV-011 + Budigalimab for Small Cell Lung Cancer
Recruiting1 awardPhase 1
Springdale, Arkansas
This trial is testing a new drug, ABBV-011, for small cell lung cancer that has come back or didn't respond to other treatments. The study has 4 parts, testing different doses of the drug and how well it works alone or with another drug, budigalimab.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.